Broadfoot Jill Marie insider trades
Broadfoot Jill Marie has filed 22 Form 4s with the SEC that we hold, for aTYR PHARMA INC (ATYR) (Chief Financial Officer), Talphera, INC. (TLPH) (Director), Cue Biopharma, Inc. (CUE) (Director) and OTIC (Director). Across all of them we count 2 purchases worth $21.9K and 4 sales worth $12.6K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($1.5K). The largest single trade was a purchase of 1,923 shares of aTYR PHARMA INC worth $13.0K, dated 2022-01-13. The first filing on our record is dated 2021-08-20 and the latest 2026-06-24.
aTYR PHARMA INC (ATYR)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-01-13 | P, purchase reported on Form 4 | 1,923 | $13.0K | 2022-01-18 | SEC |
| 2023-02-06 | S, sale reported on Form 4 | 1,566 | $3.7K | 2023-02-06 | SEC |
| 2024-02-06 | S, sale reported on Form 4 | 1,590 | $2.7K | 2024-02-06 | SEC |
| 2024-05-31 | P, purchase reported on Form 4 | 5,000 | $8.9K | 2024-06-03 | SEC |
| 2025-02-04 | S, sale reported on Form 4 | 1,254 | $4.7K | 2025-02-04 | SEC |
| 2026-02-04 | S, sale reported on Form 4 | 1,558 | $1.5K | 2026-02-04 | SEC |
Talphera, INC. (TLPH)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Cue Biopharma, Inc. (CUE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
OTIC
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1305178) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
